tirzepatide for cardiovascular disease and Outcomes: A Narrative Review of Mechanisms, Efficacy and Implications Heart Failure Management - Abdul‐Hafez - 2026 - Endocrinology, Diabetes & Metabolism Does Tirzepatide Shrink Your Heart?
Description
Primary care provider (in person)
This study demonstrates how database studies rooted in benchmarks against previously conducted randomized trials for the drugs of interest can produce complementary evidence to support expanded cardiovascular indications
If side effects are significant, stay at the current dose for an additional four weeks before reconsidering
Choose gentler meals
Side effects Most common: nausea, vomiting, diarrhea, constipation, decreased appetite, abdominal discomfort, fatigue, and injection-site reactions
